Abstract
Neurofibromatosis type 1 (NF1), an autosomal dominant and multisystem disorder, is generally considered to be caused by NF1 inactivation. However, there are also numerous studies showing that Neurofibromatosis type 1-like phenotype can be caused by the abnormalities in the other genes. Through targeted parallel sequencing, whole-exome sequencing, de novo genomic sequencing, and RNA isoform sequencing, we identified a germline V2097M variation in CSPG4 gene probably increased susceptibility to a NF1-like phenotype family. Besides, a series of in vitro functional studies revealed that this variant promoted cell proliferation by activating the MAPK/ERK signaling pathway via hindering ectodomain cleavage of CSPG4. Our data demonstrate that a germline variation in the CSPG4 gene might be a high risk to cause NF1-like phenotype. To our knowledge, this is the first report of mutations in the CSPG4 gene in human diseases.
Cite
CITATION STYLE
Bai, Z., Qu, Y., Shi, L., Li, X., Yang, Z., Ji, M., & Hou, P. (2021). Identification of a germline CSPG4 variation in a family with neurofibromatosis type 1-like phenotype. Cell Death and Disease, 12(8). https://doi.org/10.1038/s41419-021-04056-1
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.